Gilead says remdesivir coronavirus treatment reduces risk of death in severely sick patients
Gilead says remdesivir coronavirus treatment reduces risk of death in severely sick patients
The findings show that 7.6% of patients treated with remdesivir died compared with 12.5% of patients in the analysis who did not receive remdesivir treatment.